Clinical Trial Update: Propel Drug-Eluting Sinus Stent Family Open Cohort

View source ↗

Summary

This document reports that the Propel Drug-Eluting Sinus Stent open cohort trial for chronic rhinosinusitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Propel Drug-Eluting Sinus Stent (mometasone furoate)

Snippet

Sponsor: Medtronic | Conditions: Chronic Rhinosinusitis (Diagnosis) | Status: COMPLETED